Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) greatly impacts quality of life and eventually leads to premature death from respiratory failure. Inhaled treprostinil was associated with improvements in forced vital capacity (FVC) and reduced exacerbations of underlying lung disease in post hoc an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathan, Steven D, Behr, Jurgen, Cottin, Vincent, Lancaster, Lisa, Smith, Peter, Deng, CQ, Pearce, Natalie, Bell, Heidi, Peterson, Leigh, Flaherty, Kevin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255390/
https://www.ncbi.nlm.nih.gov/pubmed/35787522
http://dx.doi.org/10.1136/bmjresp-2022-001310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255390/
https://www.ncbi.nlm.nih.gov/pubmed/35787522
http://dx.doi.org/10.1136/bmjresp-2022-001310

Ejemplares similares